Is trazodone more effective than clomipramine in major depressed outpatients? A single-blind study with intravenous and oral administration

CNS Spectrums
Massimiliano BuoliAlfredo Carlo Altamura

Abstract

Some antidepressants, such as trazodone or clomipramine, can be administered intravenously in patients with major depressive disorder (MDD), with potential benefits compared to the standard oral treatment, but available data about their efficacy are limited. The present study was aimed to compare the effectiveness of trazodone and clomipramine (intravenous [i.v.] followed by oral administration). Some 42 patients with a diagnosis of MDD according to the DSM-5 were selected and treated with i.v. trazodone or clomipramine according to clinical judgment. The Hamilton Depression Rating Scale, the Hamilton Anxiety Rating Scale, and the Montgomery-Åsberg Depression Rating Scale were administered at baseline, after 2 weeks, and after 6 weeks, as well as after 1 week of intravenous antidepressant administration. Raters were blinded to type of treatment. No significant differences were found between treatment groups in terms of effectiveness at endpoint. Borderline statistical significance was found in terms of number of responders in favor of trazodone. In addition, patients treated with trazodone reported fewer total side effects than those treated with clomipramine. Both i.v. trazodone and clomipramine are rapid and effective options...Continue Reading

References

Jan 1, 1977·International Pharmacopsychiatry·G RoccatagliataC Gandolfo
Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Jul 1, 1990·DICP : the Annals of Pharmacotherapy·M W Kelly, C W Myers
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·S R BareggiA C Altamura
Jan 1, 1989·Archives of General Psychiatry·B G PollockD J Kupfer
Mar 1, 1980·General Hospital Psychiatry·D L DudleyP Loebel
May 1, 1997·The American Journal of Psychiatry·F R SalleeG Sethuraman
Sep 25, 1999·Psychiatry and Clinical Neurosciences·T HosakaH Kurosawa
Aug 23, 2002·European Archives of Psychiatry and Clinical Neuroscience·S Kasper, F Müller-Spahn
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Feb 24, 2004·Depression and Anxiety·Nidal J Moukaddam, Robert M A Hirschfeld
Jun 18, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hans-Ulrich Wittchen, Frank Jacobi
Sep 14, 2006·Current Medical Research and Opinion·Márcio MachadoThomas R Einarson
Jun 12, 2008·International Clinical Psychopharmacology·Alfredo Carlo AltamuraEmanuela Mundo
Aug 13, 2008·The Australian and New Zealand Journal of Psychiatry·Chanaka Wijeratne, Perminder Sachdev
Jan 26, 2010·CNS Spectrums·Stephen M Stahl
Aug 28, 2010·The Journal of Clinical Psychiatry·Trina Chang, Maurizio Fava
Nov 3, 2010·Psychiatry and Clinical Neurosciences·Massimiliano BuoliCarlo Altamura
Nov 30, 2012·CNS Drugs·Andrea FagioliniSiegfried Kasper
Jul 25, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders
Nov 14, 2014·Human Psychopharmacology·Massimiliano BuoliA Carlo Altamura
Nov 21, 2015·Pharmaceutical Statistics·Laura Flight, Steven A Julious
Dec 19, 2015·Expert Opinion on Pharmacotherapy·Arianna GoracciAndrea Fagiolini
Oct 30, 2016·Postgraduate Medicine·Hani Raoul Khouzam
Oct 19, 2016·Clinical Therapeutics·Jennifer L SchroeckKari A Mergenhagen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
A KonstantinidisS Kasper
© 2022 Meta ULC. All rights reserved